|
DNTH Dianthus Therapeutics Inc de 1690585 |
| Balance Sheet |
|
Current Assets
|
287,489,000 |
|
Assets
|
354,248,000 |
|
Current Liabilities
|
15,710,000 |
|
Liabilities
|
16,350,000 |
|
Equity
|
337,898,000 |
|
Shares Out
|
29,354,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-50,736,000 |
|
Investing Cash Flow
|
-263,702,000 |
| Market Analysis |
Market Cap
|
767,013,426 |
|
Price
|
20.00 |
|
BVPS
|
11.51 |
|
PB
|
1.72 |
|
EPS
|
-5.54 |
|
PS
|
3.81 |
|
FCF
|
-314,438,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DNTH documents filed with the SEC.
DNTH Filings
Clear
